Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WX-671 + Gemcitabine in Locally Advanced Pancreatic Cancer
NCT00499265Phase 2Completed
- Sponsor
- Heidelberg Pharma AG
- Start
- Apr 2007
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of Drostanolone in pancreatic cancer (PC), sponsored by Heidelberg Pharma AG. Started Apr 2007; status: completed.
02
Drugs
Drostanolone
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00499265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00499265.